SynthesisCancer chemotherapy and pharmacology2019

Equipotent doses of daunorubicin and idarubicin for AML: a meta-analysis of clinical trials versus in vitro estimation.

Sunil Adige et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.